Applicant, as named in the Orange Book
Jazz Pharms
Jazz Pharmaceuticals plc · Nasdaq: JAZZ
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Xyrem on 15 Sep 2033. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Xyrem NDA 021196 sodium oxybate | 15 Sep 2033 patent |
Recent events
- Luvox Cr · Generic approved · ANDA 220328, AppcoApproved 30 Apr 2026Detected 25 Oct 2026
- Luvox Cr · Generic approved · ANDA 220768, Micro LabsApproved 23 Jun 2026Detected 25 Oct 2026
- Xyrem · Generic approved · ANDA 210523, Ascent Pharms IncApproved 5 Nov 2025Detected 25 Oct 2026
- Luvox Cr · Generic approved · ANDA 220447, Zydus PharmsApproved 21 Jul 2026Detected 25 Oct 2026